SN
Subbu Nambi Guggenheim Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
CAI
1
Caris Life Sciences, Inc. Common Stock
CAI
$9.8B
| $34.85 | $36 |
3%
upside
| Buy | 24 days ago |
|
2
Danaher
DHR
$143B
| $200.21 | $250 |
25%
upside
| Buy | 1 month ago |
|
3
GeneDx Holdings
WGS
$3.81B
| $132.54 | $115 |
13%
downside
| Buy | 2 months ago |
|
|
TEM
4
Tempus AI, Inc. Class A Common Stock
TEM
$13.8B
| $79.62 | $75 |
6%
downside
| Buy | 2 months ago |
|
5
Neogen
NEOG
$1.25B
| $5.75 | $10 |
74%
upside
| Buy | 2 months ago |
|
6
Illumina
ILMN
$15.7B
| $98.93 | $114 |
15%
upside
| Buy | 4 months ago |
|
7
Twist Bioscience
TWST
$1.55B
| $25.76 | $50 |
94%
upside
| Buy | 4 months ago |
|
8
CryoPort
CYRX
$518M
| $10.35 | $10 |
3%
downside
| Buy | 4 months ago |
|
9
Exact Sciences
EXAS
$10.2B
| $53.81 | $60 |
12%
upside
| Buy | 4 months ago |
|
10
Veracyte
VCYT
$2.55B
| $32.43 | $37 |
14%
upside
| Buy | 5 months ago |
|
11
Guardant Health
GH
$7.5B
| $60.13 | $56 |
7%
downside
| Buy | 6 months ago |
|
12
Natera
NTRA
$23.1B
| $168.02 | $200 |
19%
upside
| Buy | 7 months ago |
|
13
Castle Biosciences
CSTL
$683M
| $23.56 | $25 |
6%
upside
| Buy | 1 year ago |
|